BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 15508176)

  • 1. Allergy assessment of foods or ingredients derived from biotechnology, gene-modified organisms, or novel foods.
    Poulsen LK
    Mol Nutr Food Res; 2004 Nov; 48(6):413-23. PubMed ID: 15508176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Will genetically modified foods be allergenic?
    Taylor SL; Hefle SL
    J Allergy Clin Immunol; 2001 May; 107(5):765-71. PubMed ID: 11344340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the potential allergenicity of the enzyme microbial transglutaminase using the 2001 FAO/WHO Decision Tree.
    Pedersen MH; Hansen TK; Sten E; Seguro K; Ohtsuka T; Morita A; Bindslev-Jensen C; Poulsen LK
    Mol Nutr Food Res; 2004 Nov; 48(6):434-40. PubMed ID: 15508178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Animal models for assessment of GMO allergenicity: advantages and limitations].
    Adel-Patient K; Wal JM
    Eur Ann Allergy Clin Immunol; 2004 Mar; 36(3):88-91. PubMed ID: 15137477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying food proteins with allergenic potential: evolution of approaches to safety assessment and research to provide additional tools.
    Ladics GS; Selgrade MK
    Regul Toxicol Pharmacol; 2009 Aug; 54(3 Suppl):S2-6. PubMed ID: 19028539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein allergenicity in mice: a potential approach for hazard identification.
    Atherton KT; Dearman RJ; Kimber I
    Ann N Y Acad Sci; 2002 May; 964():163-71. PubMed ID: 12023203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the potential allergenicity of ice structuring protein type III HPLC 12 using the FAO/WHO 2001 decision tree for novel foods.
    Bindslev-Jensen C; Sten E; Earl LK; Crevel RW; Bindslev-Jensen U; Hansen TK; Stahl Skov P; Poulsen LK
    Food Chem Toxicol; 2003 Jan; 41(1):81-7. PubMed ID: 12453731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current codex guidelines for assessment of potential protein allergenicity.
    Ladics GS
    Food Chem Toxicol; 2008 Oct; 46 Suppl 10():S20-3. PubMed ID: 18708115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits and concerns associated with biotechnology-derived foods: can additional research reduce children health risks?
    Cantani A
    Eur Rev Med Pharmacol Sci; 2006; 10(4):197-206. PubMed ID: 16910351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of the development of methodology for evaluating the human allergenic potential of novel proteins.
    Taylor SL
    Mol Nutr Food Res; 2006 Jul; 50(7):604-9. PubMed ID: 16736463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgE binding to proteins from sesame and assessment of allergenicity: implications for biotechnology?
    Orruño E; Morgan MR
    Biotechnol Lett; 2006 Dec; 28(23):1877-88. PubMed ID: 17028779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Food allergy--towards predictive testing for novel foods.
    Oehlschlager S; Reece P; Brown A; Hughson E; Hird H; Chisholm J; Atkinson H; Meredith C; Pumphrey R; Wilson P; Sunderland J
    Food Addit Contam; 2001 Dec; 18(12):1099-107. PubMed ID: 11761121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of allergenicity of genetically modified soybean protein extract in a murine model of oral allergen-specific sensitization.
    Gizzarelli F; Corinti S; Barletta B; Iacovacci P; Brunetto B; Butteroni C; Afferni C; Onori R; Miraglia M; Panzini G; Di Felice G; Tinghino R
    Clin Exp Allergy; 2006 Feb; 36(2):238-48. PubMed ID: 16433863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein allergenicity assessment of foods produced through agricultural biotechnology.
    Taylor SL
    Annu Rev Pharmacol Toxicol; 2002; 42():99-112. PubMed ID: 11807166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of cross-reactivity between the Bacillus thuringiensis derived protein Cry1F in maize grain and dust mite Der p7 protein with human sera positive for Der p7-IgE.
    Ladics GS; Bardina L; Cressman RF; Mattsson JL; Sampson HA
    Regul Toxicol Pharmacol; 2006 Mar; 44(2):136-43. PubMed ID: 16406630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The allergic risk of transgenic foods strategy for prevention].
    Moneret-Vautrin DA
    Ann Pharm Fr; 2003 Mar; 61(2):96-102. PubMed ID: 12668947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risks of allergic reactions to biotech proteins in foods: perception and reality.
    Lehrer SB; Bannon GA
    Allergy; 2005 May; 60(5):559-64. PubMed ID: 15813800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits and concerns associated with biotechnology-derived foods: can additional research reduce children health risks?
    Cantani A
    Eur Rev Med Pharmacol Sci; 2009; 13(1):41-50. PubMed ID: 19364084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performing IgE serum testing due to bioinformatics matches in the allergenicity assessment of GM crops.
    Goodman RE
    Food Chem Toxicol; 2008 Oct; 46 Suppl 10():S24-34. PubMed ID: 18715545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.